ES
Estrella Immunopharma, Inc.
ESLAW · NASDAQ
$0.06 -4.00% (-$0.00)
1M -10.18%
Market Cap $2.12M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
-
N/A P/E N/A
EV/FFO N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
57 /100
Average ROIC 131.75%
Asset turnover 0.00x
ROA 548.74%
Debt
0 /100
High Current ratio 0.20x
Debt/Equity N/A
Debt/Assets N/A
Stability
43 /100
Moderate Beta -0.09x
Profitable years 0
EPS volatility 36.25%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ESLAW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Cheng Liu
Employees
3
Headquarters
EmeryVille
Prihajajoči dogodki
02 DEC.
Earnings
Upcoming earnings report